Posted by Michael Wonder on 10 Dec 2021
Price disclosure 2022 April cycle outcomes summary
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published on the PBS website.
Indicative prices for 1 April 2022 (including price to pharmacy, dispensed price for maximum quantity and price premiums) will be published in January 2022.
The following medicines are inline for a 30% price reduction:
- Alendronic acid with colecalciferol and calcium
- Docetaxel
- 5-fluorouracil
- Nevirapine
- Pegfilgrastim
- Tenofovir disoproxil fumarate with emtricitabine
- Zoledronic acid monohydrate
